Show Stocks and Investing Publications

• Thu, January 23, 2025

by: MSN

Avidity Biosciences CFO sells $93,985 in stock

Michael F. MacLean, Chief Financial Officer of Avidity Biosciences, Inc. (NASDAQ:RNA), recently sold shares of the company stock valued at approximately $93,985. The transactions occurred on January 21,

by: WOPRAI

Short squeeze is starting in shares of EVLV at $3.91, after crossing above the $3.897 Trigger Price

by: Forbes

S&P 500 Index Funds: Risks You Must Know Before You Invest

Low cost S&P 500 index funds are fantastic investment vehicles but they are not without risks. We discuss these risks and how to best think about them.

by: Forbes

Is Quantum Computing Investable As The Next AI

Quantum computing has the potential of being the next big innovation. At the right size and the right price, it might even be investable.

by: MSN

2 'Strong Buy'-Rated Dividend Stocks With Yields Above 7% for 2025

Investing in dividend stocks with a high yield of more than 7% can significantly boost your portfolio's income potential, especially in a low-interest-rate environment. However, targeting companies with sustainable dividend payouts is crucial,

by: MSN

Altimmune's SWOT analysis: pemvidutide potential drives stock outlook

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on developing treatments for liver disease and obesity, has been garnering attention from analysts and investors alike.

by: MSN

Diamondback Energy's SWOT analysis: stock poised for growth amid merger synergies

Diamondback Energy Inc (NASDAQ:FANG), a leading independent oil and gas company focused on the Permian Basin with a market capitalization of $51.48 billion, has been making significant strides in operational efficiency and strategic growth.

by: MSN

Are famous short-sellers going extinct? The exit of Hindenburg Research and Andrew Left shows the risky trade is shrinking

The exposÃ© led to the company's CEO going to jail and to Anderson's short-selling firm, Hindenburg Research, becoming one of the most feared names in corporate America. When Anderson announced last Wednesday that Hindenburg was closing shop,

by: MSN

Is AbbVie Inc. (ABBV) the Best Halal Dividend Stock to Invest In Now?

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other halal dividend stocks.

by: MSN

Is Intel Corporation (INTC) One of the Best Socially Responsible Stocks to Buy According to Hedge Funds?

We recently compiled a list of the 8 Best Socially Responsible Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Intel Corporation (NASDAQ:INTC) stands against other best socially responsible stocks to buy according to hedge funds.

by: MSN

Is Johnson & Johnson (JNJ) the Best Halal Dividend Stock to Invest In Now?

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other halal dividend stocks.

• Fri, January 24, 2025

by: WOPRAI

Richard Hightower Maintained (MAA) at Equal with Decreased Target to $152 on, Jan 24th, 2025

by: WOPRAI

Adam Kramer Upgraded (MAA) to Overweight and Increased Target to $168 on, Jan 24th, 2025

by: WOPRAI

Arvind Ramnani Maintained (MA) at Overweight with Increased Target to $591 on, Jan 24th, 2025

by: WOPRAI

Paul Lejuez Reinstated (KR) to Neutral and Held Target at $61 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (KHC) at Hold with Decreased Target to $32 on, Jan 24th, 2025

by: WOPRAI

Nathan Jones Maintained (ITW) at Hold with Decreased Target to $266 on, Jan 24th, 2025

by: WOPRAI

Nathan Jones Maintained (ITT) at Buy with Decreased Target to $179 on, Jan 24th, 2025

by: WOPRAI

Richard Newitter Maintained (ISRG) at Buy with Increased Target to $666 on, Jan 24th, 2025

by: WOPRAI

Joanne Wuensch Maintained (ISRG) at Buy with Increased Target to $711 on, Jan 24th, 2025

by: WOPRAI

Richard Hightower Maintained (IRT) at Equal with Decreased Target to $21 on, Jan 24th, 2025

by: WOPRAI

Nathan Jones Maintained (IR) at Hold with Decreased Target to $100 on, Jan 24th, 2025

by: WOPRAI

Julien Roch Upgraded (IPG) to Overweight and Increased Target to $36 on, Jan 24th, 2025

by: WOPRAI

Adam Kramer Downgraded (INVH) to Equal and Decreased Target to $35 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (HSY) at Hold with Decreased Target to $170 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (HAIN) at Hold with Decreased Target to $7 on, Jan 24th, 2025

by: WOPRAI

Gil Luria Maintained (GOOGL) at Neutral with Increased Target to $200 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (GIS) at Buy with Decreased Target to $72 on, Jan 24th, 2025

by: WOPRAI

Matthew Akers Maintained (GE) at Overweight with Increased Target to $250 on, Jan 24th, 2025

by: WOPRAI

Ken Herbert Maintained (GE) at Outperform with Increased Target to $220 on, Jan 24th, 2025

by: WOPRAI

Terry McEvoy Reiterated (FMBH) at Equal and Held Target at $43 on, Jan 24th, 2025

by: WOPRAI

Nathan Jones Maintained (FLS) at Buy with Increased Target to $75 on, Jan 24th, 2025

by: WOPRAI

Brian Brophy Maintained (FIX) at Buy with Increased Target to $577 on, Jan 24th, 2025

by: WOPRAI

Orest Wowkodaw Maintained (FCX) at Sector with Decreased Target to $45 on, Jan 24th, 2025

by: WOPRAI

Jay Olson Downgraded (EXEL) to Perform and Decreased Target to $33 on, Jan 24th, 2025

by: WOPRAI

Christopher Mcgratty Maintained (COLB) at Market with Decreased Target to $33 on, Jan 24th, 2025

by: WOPRAI

Patrick Scholes Maintained (CCL) at Hold with Increased Target to $30 on, Jan 24th, 2025

by: WOPRAI

Lisa Gill Maintained (CAH) at Neutral with Increased Target to $142 on, Jan 24th, 2025

by: WOPRAI

Matthew Smith Maintained (CAG) at Hold with Decreased Target to $28 on, Jan 24th, 2025

by: WOPRAI

Matthew Akers Maintained (CACI) at Overweight with Increased Target to $536 on, Jan 24th, 2025

by: WOPRAI

Joseph Greff Maintained (BYD) at Neutral with Increased Target to $80 on, Jan 24th, 2025

by: WOPRAI

Fawne Jiang Reiterated (BIDU) at Buy and Held Target at $130 on, Jan 24th, 2025

by: WOPRAI

David Williams Reiterated (BDC) at Buy and Held Target at $130 on, Jan 24th, 2025

by: WOPRAI

Jared Shaw Maintained (BANC) at Overweight with Decreased Target to $19 on, Jan 24th, 2025

by: WOPRAI

Jason Gursky Maintained (BA) at Buy with Decreased Target to $207 on, Jan 24th, 2025

by: WOPRAI

Richard Hightower Maintained (AVB) at Equal with Decreased Target to $230 on, Jan 24th, 2025

by: WOPRAI

Adam Kramer Downgraded (AVB) to Equal and Decreased Target to $223 on, Jan 24th, 2025

by: WOPRAI

Karl Shepard Maintained (ASB) at Sector with Increased Target to $27 on, Jan 24th, 2025

Is Johnson & Johnson (JNJ) the Best Halal Dividend Stock to Invest In Now?

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other halal dividend stocks.

The article from MSN Money discusses whether Johnson & Johnson (JNJ) is a suitable halal dividend stock for investment. It highlights that JNJ has a long history of paying dividends, with a current yield of about 3.2%, which is attractive for dividend investors. The company's diversified business in pharmaceuticals, medical devices, and consumer health products provides stability and growth potential. However, the article points out concerns regarding the halal compliance of JNJ, particularly due to its involvement in non-halal sectors like pharmaceuticals that might include non-permissible ingredients or practices. The discussion includes considerations of JNJ's financial health, its consistent dividend increases, and its ethical practices in light of Islamic finance principles, which emphasize avoiding interest (riba), excessive uncertainty (gharar), and investments in prohibited industries. The article concludes by suggesting that while JNJ offers strong financials and a reliable dividend, potential investors should carefully evaluate its compliance with Sharia law before investing.

Read the Full MSN Article at:
https://www.msn.com/en-us/money/top-stocks/is-johnson-johnson-jnj-the-best-halal-dividend-stock-to-invest-in-now/ar-AA1xJV8I

Like: 👍

Similar Stocks and Investing Publications

on: Tue, Jan 14th 2025
by: MSN

Is Johnson & Johnson (JNJ) the Most Reliable Dividend Stock to Buy According to Hedge Funds?

We recently compiled a list of the 12 Most Reliable Dividend Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other dividend stocks.

on: Wed, Dec 25th 2024
by: MSN

Is British American Tobacco p.l.c. (BTI) the Best Dividend Stock to Buy Under $50?

We recently compiled a list of the 13 Best Dividend Stocks to Buy Under $50. In this article, we are going to take a look at where British American Tobacco p.l.c. (NYSE:BTI) stands against the other dividend stocks.

on: Sun, Jan 12th 2025
by: MSN

Invest $10,000 into these ASX dividend stocks

Analysts think these stocks could be great options for income investors. The post Invest $10,000 into these ASX dividend stocks appeared first on The Motley Fool Australia.

on: Sat, Jan 11th 2025
by: MSN

Is TELUS Corporation (TU) the Best Canadian Dividend Stock to Buy For Income Investors?

We recently compiled a list of the 10 Best Canadian Dividend Stocks to Buy For Income Investors. In this article, we are going to take a look at where TELUS Corporation (NYSE:TU) stands against the other Canadian dividend stocks.

on: Fri, Jan 03rd 2025
by: MSN

After falling 10% last year, this passive income stock yields 9.9%, and I love it

The FTSE 100 is an absolute treasure trove for passive income seekers right now. It's packed with top dividend stocks, â€¦ The post After falling 10% last year, this passive income stock yields 9.9%, and I love it appeared first on The Motley Fool UK.

on: Thu, Dec 05th 2024
by: MSN

Invest $15,000 in This Dividend Stock for $3,284.50 in Total Returns

A dividend stock can be a great portfolio addition, but don't ignore returns for a high yield. That's why we're looking at this stock. The post Invest $15,000 in This Dividend Stock for $3,284.50 in Total Returns appeared first on The Motley Fool Canada.

on: Sun, Dec 01st 2024
by: Thomas Matters

A 5.5% yield but down 30%! Is it time for me to buy this ASX 200 stock at a bargain-basement price?

Investors building passive income flows may love this defensive play idea. The post A 5.5% yield but down 30%! Is it time for me to buy this ASX 200 stock at a bargain-basement price? appeared first on The Motley Fool Australia.

on: Fri, Oct 16th 2009
by: WOPRAI

NOK, PFE, BAC, GE, LVS, WFC With Highest Daily Short Volume On NYSE Thursday

on: Wed, Oct 14th 2009
by: WOPRAI

JPM, WYE, CNO, CBS, HOG, BK With Highest Daily Short Volume On NYSE Wednesday

on: Thu, Sep 10th 2009
by: WOPRAI

KGC, HPQ, MS, MYL, CX, CAT With Highest Daily Short Volume On NYSE Wednesday

on: Thu, Aug 27th 2009
by: WOPRAI

GE, RF, WFC, F, PFE, LVS With Highest Daily Short Volume On NASDAQ BX Yesterday

on: Sun, Jan 19th 2025
by: MSN

1 Growth Stock Down 12% to Buy Right Now

One of the younger, more appealing real estate investment trusts (REITs) on the scene hasn't necessarily appealed to investors lately. Vici Properties (NYSE: VICI), which specializes in experiential properties -- primarily casinos -- is down nearly 12% in price over the past six months.